Aid Malaria Unit Acts To Regain Credibility As Probe Continues

Ex-chief Erickson pleads guilty, and a University of Illinois scientist is ousted from his laboratory. WASHINGTON--A new team at the U.S. Agency for International Development is cleaning up the mess left by the convicted ex-chief of its malaria research program. But some scientists who are looking for a vaccine for the deadly disease say that the bad odor left by the scandal leaves them wondering where their next dollar will come from. The scarcity of funds will certainly hamper the progress

Written byGeoffrey Brown
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share


Ex-chief Erickson pleads guilty, and a University of Illinois scientist is ousted from his laboratory.
WASHINGTON--A new team at the U.S. Agency for International Development is cleaning up the mess left by the convicted ex-chief of its malaria research program. But some scientists who are looking for a vaccine for the deadly disease say that the bad odor left by the scandal leaves them wondering where their next dollar will come from.

The scarcity of funds will certainly hamper the progress of finding a vaccine to protect against a disease, spread by the Anopheles mosquito, that kills 3 million people a year and may be heading to Western urban areas. But other scientists believe that the uncovering of waste and greed within the malaria research program at AID may be a blessing in disguise by deflating unrealistic expectations and providing needed oversight for the field.

The darkest chapter in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies